Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
40.55
+0.20 (0.50%)
Nov 21, 2024, 5:31 PM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 491.51 million as of November 22, 2024. Its market cap has increased by 15.41% in one year.

Market Cap
491.51M
Enterprise Value
541.00M
Revenue
149.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.55

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has decreased from 533.29M to 491.51M, a decrease of -7.83%. That is a compound annual growth rate of -0.39%.

History

DateMarket Cap% Change
Nov 20, 2024489.09M15.65%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019503.13M15.74%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 200.18B
Roche Holding AG 200.18B
Novartis AG 181.91B
Lonza Group AG 37.34B
Alcon Inc. 37.30B
Galderma Group AG 20.42B
Sonova Holding AG 17.91B
Straumann Holding AG 17.59B
Market Cap Rankings